Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals (Nasdaq: IONS) announced participation in several upcoming investor conferences.

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) announced participation in several upcoming investor conferences. Key events include:

• Guggenheim 4th Annual Immunology and Neurology Day on November 14, 2022
• Stifel 2022 Healthcare Conference on November 15, 2022
• 5th Annual Evercore ISI HealthCONx and Piper Sandler 34th Annual Healthcare Conference on November 29, 2022
• Nasdaq 47th Investor Conference and BMO 2022 Growth & ESG Conference on December 7, 2022

Live webcasts and replays will be available on Ionis’ website.

Argus Session date unavailable

+5.60% session move Open Argus

Details

News Market Reaction – IONS

The recorded move for IONS in the trading session of this news was +5.60%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., Nov. 10, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

• Guggenheim 4^th Annual Immunology and Neurology Day on Monday, November 14, 2022
• Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022
• 5^th Annual Evercore ISI HealthCONx on Tuesday, November 29, 2022
• Piper Sandler 34^th Annual Healthcare Conference on Tuesday, November 29, 2022
• Nasdaq 47^th Investor Conference on Wednesday, December 7, 2022
• BMO 2022 Growth & ESG Conference on Wednesday, December 7, 2022

A live webcast and additional information about each presentation can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. Replays will be available on the Ionis website within 48 hours of each event.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis, visit www.ionispharma.com and follow us on Twitter @ionispharma

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301672097.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Ionis Pharmaceuticals' stock symbol?

The stock symbol for Ionis Pharmaceuticals is IONS.

When will Ionis participate in the Guggenheim Immunology Day?

Ionis will participate in the Guggenheim 4th Annual Immunology and Neurology Day on November 14, 2022.

What conferences will Ionis attend in November 2022?

Ionis will attend several conferences in November 2022, including the Stifel Healthcare Conference on November 15 and the 5th Annual Evercore ISI HealthCONx on November 29.

How can I access Ionis Pharmaceuticals' investor presentations?

You can access Ionis Pharmaceuticals' investor presentations through live webcasts available on their website.

What is the date of the Nasdaq Investor Conference for Ionis?

The Nasdaq 47th Investor Conference for Ionis will take place on December 7, 2022.